Transfusion of D+ Blood in "Asia Type" DEL Recipients
Blood Transfusion Associated Adverse Reactions
About this trial
This is an interventional treatment trial for Blood Transfusion Associated Adverse Reactions
Eligibility Criteria
Criteria for eligible participant inclusion were: (1) all male "Asia type" DEL patients; (2) female "Asia type" DEL patients beyond the gestational age (≥49 years old); (3) female "Asia type" DEL patients within gestational age and having childbearing history but with no plan for further pregnancy due to malignant or severe disease.
Exclusion criteria were: (1) female "Asia type" DEL patients of childbearing age (commonly from 18 to 49 years old) with a need of pregnancy to prevent the potential alloanti-D immunization related hemolytic disease of fetus and newborn (HDFN); (2) female "Asia type" DEL children (<18 years old) to avoid adverse influence on the pregnancy.
Sites / Locations
- Guangzhou Blood Center
Arms of the Study
Arm 1
Other
"Asia type" DEL recipients
To identify "Asia type" DEL patients by phenotyping and gentoyping methods in the Chinese recipients and then blood transfusion of D+ blood rather than the rare D negative blood to the identified "Aisa type" DEL recipients.